EDIT filings
Corporate insider profile
Gilmore Neil O'Neill Filing Activity
Latest reported as CEO of Editas Medicine, Inc. (EDIT).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$41,542.92
- Latest transaction
- Jun 3, 2026
Transaction history
